31 results
8-K
EX-10.1
VTYX
Ventyx Biosciences Inc
16 May 24
Departure of Directors or Certain Officers
8:12am
or other business activity (whether full time or part-time) that would create a conflict of interest with the Company, except as approved
8-K
EX-10.2
VTYX
Ventyx Biosciences Inc
7 Mar 24
Ventyx Biosciences Announces $100 Million Private Placement of Common Stock
8:45am
counsel reasonably satisfactory to such person or (C) in the reasonable judgment of any such Person, based upon written advice of its counsel, a conflict … of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the Person notifies the indemnifying
PRE 14A
v1n b4ffr
13 Apr 23
Preliminary proxy
5:45pm
8-K
EX-3.1
kp7m47tc
12 Dec 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
EX-10.2
crs bi2j5uwnxvrw8v
19 Sep 22
Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock
8:10am
8-K
EX-10.1
qj6xd1m
9 May 22
Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer
8:07am
DEF 14A
hmuibt4i27c7v8ccfx
27 Apr 22
Definitive proxy
4:10pm
10-K
yii t6u95ilfc
23 Mar 22
Annual report
5:49pm
10-Q
zrmrfxnqby
18 Nov 21
Quarterly report
12:00am
424B4
4vqz 57lwfw82z9
21 Oct 21
Prospectus supplement with pricing info
5:10pm